Real-life Experience of Tofacitinib in Patients With Treatment-Resistant Rheumatoid Arthritis
NCT04674085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2020-12-19
Summary
The investigators aimed to present the efficacy and safety data for patients with RA who received tofacitinib therapy in outpatient clinics.
Conditions
- Rheumatoid Arthritis
- Treatment Adherence and Compliance
Sponsors & Collaborators
-
Umraniye Education and Research Hospital
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Max Age
- 68 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-01
- Primary Completion
- 2019-12-30
- Completion
- 2019-12-30
More Related Trials
-
ToFAcitinib in Early Active Axial SpondyloarThritis:
NCT06112665 ·Status: RECRUITING ·Phase: PHASE4
-
Rheumatoid Arthritis Satisfaction Outcome Research
NCT03703817 ·Status: COMPLETED
-
Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therapy in Moderate to Severe Rheumatoid Arthritis
NCT07008846 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
To Compare the Efficacy and Safety of Low-dose Glucocorticoids and Tofacitinib in Alleviating Moderate to High Disease Activity Rheumatoid Arthritis for 24 Weeks
NCT05606107 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial
NCT03738956 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis
NCT03486457 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
NCT02187055 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis
NCT04721808 ·Status: COMPLETED
-
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
NCT02092467 ·Status: COMPLETED ·Phase: PHASE4
-
Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions
NCT03073109 ·Status: COMPLETED
-
Tofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation Study
NCT06310057 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment
NCT01254331 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
NCT01245439 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis
NCT02281552 ·Status: COMPLETED ·Phase: PHASE3
-
Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
NCT06016517 ·Status: NOT_YET_RECRUITING
-
Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)-Cancer Endpoints
NCT04798287 ·Status: COMPLETED
-
Comparative Effectiveness of Targeted Therapy in RA Patients
NCT04449224 ·Status: UNKNOWN
-
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
NCT05151848 ·Status: RECRUITING ·Phase: PHASE4
-
Tofacitinib Versus Methotrexate as the First Line DMARD in the Treatment of Rheumatoid Arthritis
NCT04464642 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Tocilizumab in Patients With Rheumatoid Arthritis
NCT01187563 ·Status: COMPLETED
-
A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis
NCT01119859 ·Status: COMPLETED ·Phase: PHASE4
-
An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective
NCT02566967 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis
NCT02721004 ·Status: COMPLETED
-
A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day
NCT04267380 ·Status: COMPLETED
-
Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis
NCT05572567 ·Status: COMPLETED